Literature DB >> 30102819

Fetal microchimerism by mode of delivery: a prospective cohort study.

R Shree1, W E Harrington2, S B Kanaan3, A Forsyth3, E Cousin3, A Lopez4, J L Nelson3,5, H S Gammill1,3.   

Abstract

OBJECTIVE: To compare fetal microchimerism (FMc) in pregnancies with uncomplicated vaginal delivery (VD) versus caesarean delivery (CD).
DESIGN: Prospective cohort study.
SETTING: University of Washington and Fred Hutchinson Cancer Research Center, USA. POPULATION: Women delivering singleton pregnancies without pertinent antenatal complications with uncomplicated deliveries (n = 36).
METHODS: We collected maternal predelivery, postdelivery and umbilical cord blood for each mother-baby pair. Following maternal and fetal genotyping, FMc was measured with quantitative polymerase chain reaction assays targeting fetus-specific polymorphisms. Quantification of FMc is expressed as genome equivalents (gEq) of fetal DNA/100 000 total gEq tested. FMc detection was evaluated by logistic regression while controlling for total number of cell equivalents tested and clinically relevant covariates. FMc concentrations were compared using negative binomial regression while controlling for the same covariates and predelivery FMc positivity. MAIN OUTCOME MEASURE: Detection and concentration of FMc by mode of delivery.
RESULTS: Twenty-four mother-baby pairs had a VD and 12 had a CD. Postdelivery FMc detection was higher following CD than after VD (58.3% versus 16.7%, P = 0.02). After controlling for covariates, the likelihood of postdelivery FMc detection was almost nine-fold higher after CD than VD (odds ratio 8.8, 95% CI 1.6-47.6; P = 0.01). With respect to postdelivery FMc concentration, the detection rate ratio for CD versus VD in the adjusted negative binomial regression model was 14.7 (95% CI 3.2-66.8; P = 0.001).
CONCLUSION: Postdelivery peripheral FMc detection and concentration are significantly higher after CD than after VD. As FMc is associated with long-term maternal health, our findings suggest that the mode of delivery may impact this risk. TWEETABLE ABSTRACT: Greater fetal microchimerism found in maternal blood following caesarean delivery compared with vaginal delivery.
© 2018 Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  Caesarean delivery; maternal-fetal exchange; microchimerism; mode of delivery; pregnancy

Mesh:

Substances:

Year:  2018        PMID: 30102819      PMCID: PMC6294652          DOI: 10.1111/1471-0528.15432

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  31 in total

1.  Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma DNA.

Authors:  Y M Lo; T K Lau; L Y Chan; T N Leung; A M Chang
Journal:  Clin Chem       Date:  2000-09       Impact factor: 8.327

2.  Fetal microchimerism in women with breast cancer.

Authors:  Vijayakrishna K Gadi; J Lee Nelson
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

3.  Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction.

Authors:  Medhat S Alberry; Deborah G Maddocks; Medhat A Hadi; Helmi Metawi; Linda P Hunt; Sherif A Abdel-Fattah; Neil D Avent; Peter W Soothill
Journal:  Am J Obstet Gynecol       Date:  2009-01       Impact factor: 8.661

4.  Fetal microchimerism in breast from women with and without breast cancer.

Authors:  Vijayakrishna K Gadi
Journal:  Breast Cancer Res Treat       Date:  2009-09-19       Impact factor: 4.872

5.  Prospective study of fetal DNA in serum and disease activity during pregnancy in women with inflammatory arthritis.

Authors:  Zhen Yan; Nathalie C Lambert; Monika Ostensen; Kristina M Adams; Katherine A Guthrie; J Lee Nelson
Journal:  Arthritis Rheum       Date:  2006-07

6.  Microchimerism of maternal origin persists into adult life.

Authors:  S Maloney; A Smith; D E Furst; D Myerson; K Rupert; P C Evans; J L Nelson
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

Review 7.  Naturally acquired microchimerism.

Authors:  Hilary S Gammill; J Lee Nelson
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

8.  Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer.

Authors:  Nathalie C Lambert; Y M Dennis Lo; Timothy D Erickson; Tracy S Tylee; Katherine A Guthrie; Daniel E Furst; J Lee Nelson
Journal:  Blood       Date:  2002-10-15       Impact factor: 22.113

9.  Autoimmune disease during pregnancy and the microchimerism legacy of pregnancy.

Authors:  Kristina M Adams Waldorf; J Lee Nelson
Journal:  Immunol Invest       Date:  2008       Impact factor: 3.657

10.  Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction: studies of healthy women and women with scleroderma.

Authors:  Nathalie C Lambert; Timothy D Erickson; Zhen Yan; Jennifer M Pang; Katherine A Guthrie; Daniel E Furst; J Lee Nelson
Journal:  Arthritis Rheum       Date:  2004-03
View more
  3 in total

1.  Umbilical Cord Maternal Microchimerism in Normal and Preeclampsia Pregnancies.

Authors:  Raj Shree; Stephen McCartney; Emma Cousin; Angel Chae; Hilary S Gammill; J L Nelson; Sami B Kanaan
Journal:  Reprod Sci       Date:  2022-09-27       Impact factor: 2.924

Review 2.  Nonendocrine mechanisms of sex bias in rheumatic diseases.

Authors:  Nathalie C Lambert
Journal:  Nat Rev Rheumatol       Date:  2019-10-09       Impact factor: 20.543

Review 3.  Feto-maternal microchimerism: Memories from pregnancy.

Authors:  Blanca Cómitre-Mariano; Magdalena Martínez-García; Bárbara García-Gálvez; María Paternina-Die; Manuel Desco; Susanna Carmona; María Victoria Gómez-Gaviro
Journal:  iScience       Date:  2021-12-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.